Zdrowie i gospodarka · 20/05/2003
FDA's Endocrinologic and Metabolic Drugs Advisory Committee to Review Proposed Changes to Diabetes Medication Notice
The Endocrinologic and Metabolic Drugs Advisory Committee will review proposed amendments to a notice related to diabetes medications, as requested by the FDA
Source: Federal Register — Food and Drug AdministrationOpen original release →